Epigenome Editing for Cannabinoid Yield: Targets, Tools, and Priorities in Cannabis sativa

Cannabinoid content can vary several-fold across Cannabis sativa L. cultivars that carry functional, closely related CBDA synthase (CBDAS) and THCA synthase (THCAS) alleles, a difference that coding-sequence variation among functional alleles does not fully explain. Structural and copy-number variation at the synthase loci, the functional or pseudogenised state of synthase alleles, and linkage at the B locus account for much of the qualitative drug-versus-hemp chemotype; however, these genetic factors do not fully explain the quantitative, several-fold variation in cannabinoid content among cultivars that carry functional, near-identical synthase alleles. Three independent lines of evidence now indicate that chromatin-level regulation contributes to this variation. H3K4me3 and H3K56ac co-occupy the promoters and gene bodies of THCAS, CBDAS, OLS, and OAC exclusively in glandular trichome tissue while H3K27me3 marks the identical loci in vegetative tissues, indicating that a Polycomb-to-Trithorax chromatin switch is associated with trichome-specific cannabinoid gene expression, potentially independently of transcription factor availability. Progressive DNA hypomethylation accumulates during micropropagation in a cultivar-specific manner, with promoter-region differentially methylated positions reaching up to 22% by twenty subcultures, identifying DNA methylation maintenance as a candidate determinant of epigenetic stability in clonally propagated material, although the functional consequences for cannabinoid pathway gene expression and yield remain to be quantitatively established. In Cannabis indica cell suspension cultures, UV irradiation increases genome-wide DNA methylation (detected by MSAP, which does not resolve locus-specific changes) and elevates CBDAS transcript levels approximately 4-fold relative to non-irradiated controls. This coupling of an environmentally triggered methylation change to cannabinoid pathway gene expression in the Cannabis genus is suggestive, but the genome-wide MSAP signal and the use of C. indica cell cultures mean the locus-specific methylation change at the CBDAS promoter remains to be demonstrated. These findings identify specific, experimentally documented chromatin states as candidate targets for dCas9-effector intervention, including the H3K27me3 repressive state at cannabinoid loci that could be addressed by dCas9-KDM6A and the propagation-induced CG hypomethylation that could be addressed by dCas9-DNMT3A; these editing strategies remain hypotheses that have not yet been tested in Cannabis. We synthesize functional evidence from Catharanthus roseus, Papaver somniferum, and Artemisia annua demonstrating that equivalent chromatin switches control secondary metabolite yield in medicinal plants, evaluate which dCas9-effector architectures are most appropriate for each Cannabis chromatin target, and identify the critical mechanistic gaps that must be closed before epigenome editing can be rationally deployed for cannabinoid yield enhancement in Cannabis.